Editorial Retraction: A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus

References

1. Sabine Maria Bird. Investigating a potential role for irisin as a biomarker in the early detection of Alzheimer's disease [dissertion]. The University of Western Australia; 2018. 402p. DOI:10.4225/23/5b2af9560e3f7
2. Thomas G. Brock. Weight Loss: A New Star is Irisin [Internet]. Cayman Chemical; [cited 2020 March 26]. Available from: https://www.caymanchem.com/news/weight-loss-and-irisin/.
3. Perakakis N, Triantafyllou GA, Fernandez-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nature. 2017;13:324-37. DOI:10.1038/nrendo.2016.221
4. Xiong XQ, Chen D, Sun HJ, Ding L, Wang JJ, Chen Q, et al. FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. BBA Molecular Basis of Disease. 2015;1852(9):1867-75. DOI:10.1016/j.bbadis.2015.06.017
5. Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Clinical Science. 2015;129(10):839-50. DOI:10.1042/CS20150009
6. Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-$1{\alpha}$-irisin-betatrophin axis. Adipocyte. 2013;3(1):67-8. DOI:10.4161/adip.27370